Adjuvant nivolumab plus ipilimumab versus placebo for localised renal cell carcinoma after nephrectomy (CheckMate 914): a double-blind, randomised, phase 3 trial
Titel:
Adjuvant nivolumab plus ipilimumab versus placebo for localised renal cell carcinoma after nephrectomy (CheckMate 914): a double-blind, randomised, phase 3 trial
Auteur:
Motzer, Robert J Russo, Paul Grünwald, Viktor Tomita, Yoshihiko Zurawski, Bogdan Parikh, Omi Buti, Sebastiano Barthélémy, Philippe Goh, Jeffrey C Ye, Dingwei Lingua, Alejo Lattouf, Jean-Baptiste Albigès, Laurence George, Saby Shuch, Brian Sosman, Jeffrey Staehler, Michael Vázquez Estévez, Sergio Simsek, Burcin Spiridigliozzi, Julia Chudnovsky, Aleksander Bex, Axel